309 related articles for article (PubMed ID: 9082363)
1. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
2. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications.
Miettinen M; Kovatich AJ; Kärkkäinen P
Virchows Arch; 1997 Dec; 431(6):407-13. PubMed ID: 9428928
[TBL] [Abstract][Full Text] [Related]
3. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
[TBL] [Abstract][Full Text] [Related]
4. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
Raphael SJ; McKeown-Eyssen G; Asa SL
Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
[TBL] [Abstract][Full Text] [Related]
5. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.
Fonseca E; Nesland JM; Höie J; Sobrinho-Simões M
Virchows Arch; 1997 Mar; 430(3):239-45. PubMed ID: 9099982
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
Guyétant S; Michalak S; Valo I; Saint-André JP
Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
[TBL] [Abstract][Full Text] [Related]
7. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
Schelfhout LJ; Van Muijen GN; Fleuren GJ
Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
9. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
10. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
[TBL] [Abstract][Full Text] [Related]
11. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
12. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
13. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis.
Choe W; Kim S; Hwang TS; Lee SS
Pathol Int; 2003 Jul; 53(7):434-9. PubMed ID: 12828608
[TBL] [Abstract][Full Text] [Related]
14. Raf-1 kinase inhibitory protein expression in thyroid carcinomas.
Kim HS; Kim GY; Lim SJ; Kim YW
Endocr Pathol; 2010 Dec; 21(4):253-7. PubMed ID: 20734161
[TBL] [Abstract][Full Text] [Related]
15. Papillary and follicular neoplasms of the thyroid gland. Differential immunohistochemical staining with high-molecular-weight keratin and involucrin.
Liberman E; Weidner N
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):42-8. PubMed ID: 10937048
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
18. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland.
Bhargav PR; Gayathri KB
Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114
[No Abstract] [Full Text] [Related]
19. [Expression of galectin-3 in thyroid gland and follicular cell tumors of the thyroid. A critical study of its possible role in preoperative differential diagnosis].
Niedobitek C; Niedobitek F; Lindenberg G; Bachler B; Neudeck H; Zuschneid W; Hopfenmüller W
Pathologe; 2001 May; 22(3):205-13. PubMed ID: 11402851
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]